Cryptic resistance mutations associated to misdiagnoses of Multidrug-resistant tuberculosis (deep amplicon sequencing)

This study describes how using whole genome sequencing with deep amplicon sequencing we have been able to identify and validate new drug resistance mutations in first-line anti TB antibiotics.